Effects of Empagliflozin and Lifestyle Intervention on Improving Body Weight and Other Metabolic Parameters in Atypical Antipsychotics-treated Patients with Schizophrenia Spectrum Disorders-A Double-blind Randomized Placebo-controlled Trial.
来源：PubMed发布日期：2026-04-10作者：Wong SY, Chan SC, Mo YF, Tsoh J, Wong WO1 次点击